Chemcrux Enterprises Ltd (CHEMCRUX) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Chemcrux Enterprises Ltd on NSE and BSE, with an AI summary of each filing.
Unaudited Financial Results - 30.09.2026
Financial Result · 04 Nov 2026, 12:02 am
Chemcrux Enterprises Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lacs) ■ Revenue: 2,384 (+34.4% YoY | +8.7% QoQ) ■ EBITDA: 285 (+59.0% YoY | +5.7% QoQ) ■ EBITDA Margin (%): 12.0 (+185 bps YoY | -33 bps QoQ) ■ PAT: 54.8 (+157.4% YoY | +8.5% QoQ) ■ EPS (INR): 0.37 (+164.3% YoY | +8.8% QoQ)
Unaudited Financial Results - 30.09.2026
Financial Result · 02 Nov 2026, 8:06 pm
Chemcrux Enterprises Q2 FY27 Consolidated Net Profit Surges 157% YoY Chemcrux Enterprises reported strong Q2 FY27 results, with consolidated revenue from operations rising 34.4% YoY to ₹2,384.41 lacs from ₹1,774.63 lacs in Q2 FY26 (up 8.7% QoQ). Consolidated net profit surged 157.4% YoY to ₹54.80 lacs versus ₹21.29 lacs in Q2 FY26. Half-year consolidated net profit grew to ₹105.32 lacs from ₹30.55 lacs YoY. On a standalone basis, Q2 FY27 revenue reached ₹2,384.30 lacs with net profit doubling YoY to ₹162.42 lacs. Operating cash flows improved significantly to ₹1,412.18 lacs for H1 FY27.
Unaudited Standalone & Consolidated Financial Results for the quarter and half year ended 30th September 2026 for F.Y. 2026-27 along with Limited Review Report
Outcome · 02 Nov 2026, 8:00 pm
Chemcrux Enterprises Approves Q2 and H1 FY27 Financial Results Chemcrux Enterprises announced that its Board of Directors met on 2nd Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26 (FY26-27). The board also reviewed the accompanying Limited Review Report recommended by the Audit Committee. The meeting commenced at 11:00 AM and concluded at 2:20 PM.
Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve 1. Unaudited Financial ....
Intimation · 02 Nov 2026, 5:30 am
ChemCrux Enterprises Board Meeting Scheduled for 2nd Nov'26 to Approve Q2/H1 Financials ChemCrux Enterprises Ltd. announced that its Board of Directors will meet on 2nd Nov'26 to consider and approve the unaudited financial results for the quarter and half-year ended 30th Sep'26 (FY26-27). The board meeting will be preceded by an Audit Committee meeting on the same day. Additionally, the trading window for dealing in company shares by designated persons remains closed from 1st Oct'26 until 48 hours following the public announcement of the financial results on 2nd Nov'26.
Regularisation of appointment of Ms. Zarna Pankaj Thakar (DIN: 11869662) as an Independent Director (Non-Executive) by members of the Company at 30th AGM
Change in Management · 19 Sept 2026, 12:10 am
Submission of e-voting results and Scrutinizer''s report for 30th AGM held on 17th September 2026
Annual General Meeting · 19 Sept 2026, 12:01 am
Summary of proceedings of 30th AGM held today i.e., Thursday, 17th September 2026 at 2:00 p.m. (IST) through VC/ OAVM is enclosed pursuant to Reg. 30 of SEBI (LODR) Regulations, 2015.
Annual General Meeting · 17 Sept 2026, 10:49 pm
Letter to shareholders containing the web-link of the Notice and Annual Report for 30th AGM.
Annual General Meeting · 24 Aug 2026, 11:14 pm
Communication for TDS on dividend for F.Y. 2025-26
Dividend · 24 Aug 2026, 10:57 pm
Chemcrux Enterprises Declares FY26 Final Dividend of ₹1.00 Per Share Chemcrux Enterprises’ board has recommended a final dividend of ₹1.00 per share (face value ₹10) for FY26. Subject to shareholder approval at the AGM on 17th Sep'26, the dividend will be paid by 17th Oct'26. The record date is set for 10th Sep'26. The company will deduct tax at source (TDS) as per applicable income tax laws. For resident individuals, TDS is 10%, though not applicable if the total dividend is below ₹10,000. Non-resident TDS is 20%, subject to DTAA benefits.
Cessation of term of Independent Directors of the Company: Mr. Bhanubhai Patel (DIN: 00727280) and Mr. Shailesh Patel (DIN: 02826895) pursuant to completion of their Tenure - 2 terms of ....
Change in Management · 24 Aug 2026, 10:48 pm
Chemcrux Announces Departure of Two Independent Directors Chemcrux Enterprises announced the cessation of two Independent Directors, Mr. Bhanubhai Patel and Mr. Shailesh Patel, effective 23rd Aug'26. The departures are due to the completion of their respective tenures, which consisted of two consecutive five-year terms. The company confirmed there are no other material reasons for their cessation. This change in board composition follows standard regulatory requirements and marks a routine transition in governance for the company (BSE: 540395).
Record Date for Final Dividend - 10th September 2026
Dividend · 21 Aug 2026, 10:35 pm
Chemscrux Sets Record Date for FY26 Final Dividend Chemcrux Enterprises (BSE: 540395) has fixed 10th Sep'26 as the record date for determining shareholder eligibility for the final dividend for the year ended 31st Mar'26. The dividend, if approved at the 30th AGM on 17th Sep'26, will be paid on or before 17th Oct'26. Shareholders whose names are on the register as of the record date will be entitled to the payment.
Notice of 30th AGM to be held on Thursday, 17th September 2026 at 2:00 p.m. (IST) through VC/OAVM.
Annual General Meeting · 21 Aug 2026, 9:58 pm
Annual Report for the F.Y. 2025-26
Others (Uncategorized) · 21 Aug 2026, 9:36 pm
Resignation of Mrs. Sidhdhi Girishkumar Shah (DIN: 00469138) - Non-Executive, Non-Independent Director w.e.f. 4th August 2026. Resignation letter is attached.
Change in Management · 05 Aug 2026, 1:15 am
Chemcrux Non-Executive Director Sidhdhi Girishkumar Shah Resigns Chemcrux Enterprises announced that its board accepted the resignation of Mrs. Sidhdhi Girishkumar Shah, a Non-Executive, Non-Independent Director, effective 04th Aug'26. She also stepped down as Chairperson of the Stakeholders Relationship Committee. The stated reason for her departure is "pre-occupation," with confirmation that no other material reasons exist. Shah confirmed she does not hold any directorships or committee memberships in any other listed entities.
Appointment of Ms. Zarna Pankaj Thakar (DIN: 11869662) as an Additional Director (Non-Executive, Independent) w.e.f. 4th August 2026; subject to regularisation by shareholders at ensuing AGM
Change in Management · 05 Aug 2026, 1:13 am
Unaudited Financial Results for the quarter ended 30th June 2026
Financial Result · 05 Aug 2026, 1:05 am
Chemcrux Enterprises Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lacs) ■ Revenue: 2,194 (+32.9% YoY | -9.7% QoQ) ■ EBITDA: 270 (+65.9% YoY | -35.6% QoQ) ■ EBITDA Margin (%): 12.3 (+244 bps YoY | -496 bps QoQ) ■ PAT: 50.5 (+445.0% YoY | -72.7% QoQ) ■ EPS (INR): 0.34 (+466.7% YoY | -72.8% QoQ)
The Board of Directors of the Company at their meeting held today i.e., Tuesday, 04th August 2026 at the Registered Office of the Company at 330, Trivia Complex, Natubhai Circle, Racecourse, ....
Outcome · 05 Aug 2026, 1:01 am
Chemcrux Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve 1. Unaudited Financial ....
Intimation · 04 Aug 2026, 5:30 am
Chemcrux Enterprises Board Meeting Scheduled for Q1FY27 Results Chemcrux Enterprises Ltd. has scheduled a Board of Directors meeting for 04 Aug'26 to consider and approve the unaudited financial results for the quarter ended 30 Jun'26 (Q1FY27). The trading window for designated persons, which was closed from 01 Jul'26, will reopen 48 hours after the results are publicly declared on 04 Aug'26. The board meeting will be preceded by an Audit Committee meeting on the same day to review the financial statements.
Updates on Acquisition - Incorporation of Chemcrux Foundation (Section 8 Company)
Others (Uncategorized) · 17 Jul 2026, 9:05 pm
Chemcrux Enterprises Incorporates Non-Profit Subsidiary for CSR Activities Chemcrux Enterprises announced on 17th Jul'26 the incorporation of a wholly-owned subsidiary, Chemcrux Foundation. The new entity is a Section 8 non-profit company formed to fulfill the parent company's CSR obligations. Chemcrux acquired 100% of the shares for a total cash consideration of Rs. 1,00,000, representing 10,000 equity shares at a face value of Rs. 10 each. The new subsidiary is yet to commence operations. The transaction is classified as a related-party transaction due to common directors and promoters.
The NRC has granted 107700 stock options to eligible employees pursuant to ESOP 2025/ Scheme. The grant date for ESOP Grant 1 - 2026 will be 15th May 2026.
Others (Uncategorized) · 14 May 2026, 11:20 pm
Chemcrux Grants 107,700 Stock Options Under ESOP 2025 Chemcrux Enterprises announced the grant of 107,700 stock options to eligible employees under its ESOP 2025 scheme. The grant date is set for 15th May'26. Each option is convertible into one equity share with a face value of Rs. 10 and has an exercise price of Rs. 10 per share. The options will vest 100% after one year from the grant date and can be exercised within three years from vesting, contingent on continued employment. This grant will involve a new issue of equity shares.
Kalichem Private Limited (WOS) as part of its proposed diversification into inorganic chemical sector has filed CTE Amendment to GPCB for addition of various inorganic chemicals.
Others (Uncategorized) · 14 May 2026, 10:10 pm
Chemcrux Subsidiary Seeks Approval for Inorganic Chemicals Diversification Chemcrux Enterprises announced on 14th May'26 that its wholly-owned subsidiary, Kalichem Private Limited, is diversifying into the inorganic chemicals sector. As part of this strategy, Kalichem has applied to the Gujarat Pollution Control Board for a "Consent to Establish" amendment. This amendment is for the addition of various inorganic chemicals at its manufacturing facility in Moksi, Vadodara, Gujarat. This move signals a strategic expansion of the company's product portfolio into a new chemical segment, pending regulatory approval.
The Board at their meeting held today (14.05.2026) approved to incorporate a non-profit making company u/s 8 of the Companies Act, 2013 as the Wholly owned subsidiary of the Company; subject ....
Others (Uncategorized) · 14 May 2026, 10:06 pm
Chemcrux to Set Up Non-Profit Subsidiary, Declares FY26 Dividend Chemcrux Enterprises' board, on 14 May'26, approved Q4 and FY26 financial results and recommended a final dividend of 10% (Rs. 1/- per share) for FY26. The board also approved the incorporation of a non-profit, wholly-owned subsidiary under Section 8 of the Companies Act, 2013. This new entity will be established to fulfill the company's CSR obligations. The incorporation is subject to regulatory approvals. The acquisition will be funded via cash consideration for 100% of the subsidiary's shares.
Recommendation of Final Dividend at rate of 10% (Re. 1/- per share) on the equity share of Rs. 10/- each subject to approval of members at ensuing AGM
Dividend · 14 May 2026, 10:03 pm
Chemcrux Board Approves FY26 Results, Dividend, and New Subsidiary Chemcrux Enterprises' board, in its meeting on 14th May'26, approved the audited financial results for the quarter and year ended 31st Mar'26. The board recommended a final dividend for FY25-26 of Re. 1/- per share (10% on Rs. 10/- face value), subject to shareholder approval. It also approved the incorporation of a new wholly-owned, non-profit subsidiary under Section 8 of the Companies Act, 2013. The subsidiary, to be established with a paid-up capital of Rs. 1,00,000, will fulfill the company's CSR obligations.
Audited Financial Results for the quarter and year ended 31.03.2026
Financial Result · 14 May 2026, 9:59 pm
CHEMCRUX ENTERPRISES LIMITED - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lacs) ■ Revenue: 2428 (+54.4% YoY | +9.8% QoQ) ■ EBITDA: 419 (+98.5% YoY | +18.6% QoQ) ■ EBITDA Margin (%): 17.2 (+383 bps YoY | +128 bps QoQ) ■ PAT: 185 (+807.1% YoY | +17.4% QoQ) ■ EPS (INR): 1.25 (+792.9% YoY | +17.9% QoQ)
Outcome of Board Meeting held on 14th May 2026. The Board approved: 1. Audited Standalone & Consolidated Financial Statements & Results for the Quarter and Year Ended 31st March 2026 2. ....
Outcome · 14 May 2026, 9:53 pm
CHEMCRUX ENTERPRISES LTD. - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakh) ■ Revenue: 3744 (+29.2% YoY | +8.3% QoQ) ■ EBITDA: 1056 (+49.6% YoY | +10.6% QoQ) ■ EBITDA Margin (%): 28.2 (+384 bps YoY | +57 bps QoQ) ■ PAT: 758 (+58.1% YoY | +12.4% QoQ) ■ EPS (INR): 6.84 (+58.3% YoY | +12.5% QoQ)